Tip #2: Rare Optic Nerve Complications and Vision Changes
Your visual health directly impacts your quality of life, from enjoying your favorite hobbies to driving safely around your community. In July 2024, a landmark study led by Harvard-affiliated Mass Eye and Ear and published in JAMA Ophthalmology highlighted an important visual safety concern. Researchers discovered that patients with type 2 diabetes taking semaglutide were 4.28 times more likely to develop Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) compared to those on other diabetes treatments. Over a three-year period, 8.9% of semaglutide patients in the study developed this condition, compared to just 1.8% of patients on non-GLP-1 medications.
NAION is a severe optic nerve condition caused by reduced blood flow to the eye, potentially leading to sudden and irreversible vision loss. While the overall incidence remains relatively low, the stark increase in risk means you must remain vigilant about any sudden visual disturbances.
Protect your eyesight by scheduling comprehensive dilated eye exams before starting treatment and maintaining annual check-ups with your optometrist or ophthalmologist. If you notice blurry vision, dark spots, or a sudden loss of sight in one eye, contact your physician immediately. Early detection and prompt communication with your medical team ensure that your eyes receive the protection they deserve.
